An article published in the International Journal of Clinical Medicine in September, 2011 (ijcm, 2011, 2, 473-477,http://www.scirp.org/journal/PaperDownload.aspxpaperID=7563&returnUrl=http%3a%2f%2fwww.scirp.org%2fJournal%2fHome.aspx%3fIssueID%3d1074 ) entitled Topical Solasodine Rhamnosyl Glycosides Derived from the Eggplant Treats Large Skin Cancers: Two Case Reports by Dr. Bill Cham at the Australasian Medical Research Centre has received tremendous interest with a record high downloads/citations when compared with articles of over 150 scientific journals of the same publishers SCIRP.
SCIRP (Scientific Research Publishing) is an academic publisher of open access journals. It also publishes academic books and conference proceedings. SCIRP currently has more than 150 open access journals in the areas of science, technology, and medicine. So the record downloads of the above article means this article has been of interest to readers when compared to more than tens of thousands of other articles published by SCIRP and indeed the Curaderm BEC5 article is the most popular ever published by SCIRP.
The above article describes the effectiveness of Curaderm BEC5 on two very large skin cancers. The anticancer active ingredients were extracted from the eggplant or devil’s apple. Photographs of skin cancers before, during and after treatment with Curaderm BEC5 are almost unbelievable. The patients did not experience any side effects. At the completion of treatment with Curaderm BEC5, it could not be distinguished where the tumours once were! No other studies using other methods such as surgery even when followed up with surgical cosmetic reconstruction can achieve such results.
Figure 1 shows an example of a Curaderm BEC5 treated skin cancer. In additon to eliminating this large skin cancer with Curaderm BEC5, the treatment also improved the quality of life for these patients. Curaderm BEC5 continues to amaze the medical profession.